[
    [
        {
            "time": "",
            "original_text": "[强于大市评级]医药行业周报：中美贸易摩擦持续看好医药牛市 推荐智飞生物、康泰生物、贝瑞基因等",
            "features": {
                "keywords": [
                    "医药",
                    "中美贸易摩擦",
                    "牛市",
                    "智飞生物",
                    "康泰生物",
                    "贝瑞基因"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "[强于大市评级]医药行业周报：中美贸易摩擦持续看好医药牛市 推荐智飞生物、康泰生物、贝瑞基因等",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "[增持评级]联讯医药行业2017年报及2018Q1季报总结：行业整体扣非净利增速下降 业绩明显分化下关注结构性机会",
            "features": {
                "keywords": [
                    "医药",
                    "2017年报",
                    "2018Q1季报",
                    "扣非净利",
                    "增速下降",
                    "业绩分化",
                    "结构性机会"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "[增持评级]联讯医药行业2017年报及2018Q1季报总结：行业整体扣非净利增速下降 业绩明显分化下关注结构性机会",
                "Correlation": 7,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 5,
                "Duration": 7,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 4,
                "Headline_Structure": 7,
                "Source_Recency": 5
            }
        },
        {
            "time": "",
            "original_text": "医药股表现分化",
            "features": {
                "keywords": [
                    "医药股",
                    "表现分化"
                ],
                "sentiment_score": 0.4,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "医药股表现分化",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 5,
                "Impact": 4,
                "Duration": 4,
                "Entity_Density": 2,
                "Market_Scope": 8,
                "Time_Proximity": 5,
                "Headline_Structure": 3,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "[买入评级]智飞生物(300122)：九价HPV疫苗代理权如期落地 业绩爆发可期",
            "features": {
                "keywords": [
                    "智飞生物",
                    "九价HPV疫苗",
                    "代理权",
                    "业绩爆发"
                ],
                "sentiment_score": 0.95,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "[买入评级]智飞生物(300122)：九价HPV疫苗代理权如期落地 业绩爆发可期",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 7,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        }
    ]
]